“…Markov models provide a popular statistical approach for capturing the progression of chronic diseases (Aalen, et al, 1997, Corpechot, et al, 2000, Deuffic-Burban, et al, 2002, Gentleman, et al, 1994, Hsieh, et al, 2002, Kay, 1986, Longini, et al, 1989, Rangel-Frausto, et al, 1998). The models are also widely applied to investigate neurodegenerative disease processes such as AD dementia (Abner, et al, 2012, Commenges, et al, 2004, Harezlak, et al, 2003, Kryscio, et al, 2006, Salazar, et al, 2007, Yu, et al, 2010). The central structure of the model is represented by a transition probability or intensity (i.e.…”